Dr. Botta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10666 N Torrey Pines Rd
K323
La Jolla, CA 92037Phone+1 858-554-3200Fax+1 858-554-3232
Summary
- Dr. Gregory Botta is a physician-scientist specializing in Gastrointestinal Oncology. Dr. Botta accepts new patients at the UCSD Moores Cancer Center, an NCCN designated comprehensive cancer center. His laboratory specializes in pancreatic cancer drug targeting, immune profiling, regeneration, and artificial intelligence. Currently he is involved in the Phase 1 trial of CendR peptide in Pancreatic Cancer and has many clinical trial options through the GI Oncology Research Program at UCSD. Dr. Botta is a graduate of Carnegie Mellon University in Information Systems and Biomedical Engineering. He graduated with his MD and PhD from Drexel University in Molecular, Cellular Biology & Genetics. His post-doctoral work was completed in the GI Division at the University of Pennsylvania. He completed his Medicine Residency and Medical Oncology Fellowship at the Scripps Clinic and MD Anderson Cancer Center.
Education & Training
Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019- Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 2015 - 2016
- Scripps Clinic/Scripps Green HospitalInternship, Internal Medicine, 2014 - 2015
University of Pennsylvania Health SystemPost-Doctoral Fellowship, Gastroenterology, 2012 - 2014
Drexel University College of MedicineClass of 2014
Drexel University / University of PennsylvaniaPhD, Molecular Biology & Genetics, Bondi Award, 2008 - 2012- University of PittsburghGraduate Studies, Biomedical Engineering, 2004 - 2006
- Carnegie Mellon UniversityBS, Information Systems & Biomedical Engineering, Honors, 2000 - 2004
Certifications & Licensure
CA State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.Jonathan Weitz, Daisuke Nishizaki, Joy Liau, Jay Patel, Isabella Ng
Journal of Clinical Oncology. 2024-10-16 - 2 citationsAssociation of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, Vasily N Aushev, Abdullah Esmail
The Oncologist. 2024-10-03 - 1 citationsRole of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases.Joel M Baumgartner, Gregory P Botta
Journal of Gastrointestinal Cancer. 2024-03-01
Authored Content
- Cyclosporine for Ulcerative ColitisJanuary 2014
Press Mentions
Natera to Present Latest Signatera™ MRD Data in Colorectal and Pancreatic Cancers at the ASCO GI Symposium 2022, and Host Special Investor CallJanuary 19th, 2022- Early Cancer Recurrence Detection: A Tumor-Informed ApproachApril 5th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
